Author:
Olausson Michael,Mjörnstedt Lars,Brynger Hans,Blohmé Ingemar
Publisher
Springer Berlin Heidelberg
Reference5 articles.
1. Neuhaus P, Bechstein WO, Blumhardt G, Wiens M, Lemmens P, Langrehr JM, Lohmann R, Steffen R, Schlag H, Slama K-J, Lobeck H (1993) Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 55: 1320–1327
2. Steininger R, Mühlbacher F, Hamilton G, Längle F, Gnant M, Popow T, Sautner T, Götzinger P, Wamser P, Stockenhuber F, Mirza D, Piza F (1991) Comparison of CyA, OKT3, and ATG immunoprophylaxis in human liver transplantation. Transplant Proc 23: 2269–2271
3. Birkeland SA (1975) A controlled clinical trial of treatment with ALG on established rejection of renal allografts. Acta Med Scand 198: 489
4. Abouna GM, Al-Abdullah IH, Kelly-Sullivan D, Kumar MSA, Loose J, Phillips K, Yost S, Seirka D (1995) Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 59: 1564–1568
5. Bock HA, Gallati H, Zürcher RM, Bachofen M, Mihatsch MJ, Landman J, Thiel G (1995) A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 59: 830–840